CHICAGO, Sept. 07, 2017 -- In the second quarter of 2017, Rothman Institute selected Allscripts (NASDAQ:MDRX) Practice Management as its core financial platform, replacing its legacy system. Allscripts PM will help Rothman Institute manage scheduling, collections, claims and denials, maximizing the organization’s revenue.
Rothman Institute, based in Philadelphia, PA, is a global leader in Orthopedic science and technology. Rothman Institute’s sports medicine team evaluates more than 80,000 sports injuries and performs more than 10,000 surgeries each year. Additionally, Rothman’s clinical staff serves as team physicians for the Philadelphia Eagles, Philadelphia Flyers, Philadelphia 76ers and more than 40 local high schools and colleges.
Allscripts PM is a comprehensive revenue cycle management solution for physician practices and large hospital organizations. The solution helps physicians addresses some of the challenges they face today such as shifting from fee-for-service to value-based care, consolidation, meeting complex regulations and maximizing reimbursement. Allscripts PM’s open architecture enables the sharing of patient information across multiple platforms and streamlines accounts receivable.
“Rothman Institute chose the Allscripts Practice Management solution because it closely aligns with our goals to continuously improve our financial and operational performance,” said Rothman Institute’s Chief Information Officer, Lancer Seaman. “The solution provides the tools we need to enhance revenue cycle operations and increase efficiencies of reimbursement processes and patient payments.”
"We are honored to partner with the Rothman Institute to help the prestigious organization navigate the challenging financial and operational landscape of today’s healthcare IT industry,” said Allscripts Senior Vice President and General Manager Ambulatory Business Unit, Steve Lalonde. “Our goal is to help Rothman Institute get reimbursed for the services they provide and free up time and resources so they can focus on providing quality care to its community.”
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact: Investors: Seth Frank 312-506-1213 [email protected] Media: Concetta Rasiarmos 312-447-2466 [email protected]


Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Apple Turns 50: From Garage Startup to AI Crossroads
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



